| Steeghs N, Gelderblom H, Wessels J, et al.
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors. [JOURNAL ARTICLE]
Invest New Drugs 2009 Nov 19.
Abstract | Full Citation | Find Related Articles | | Monaghan K, Khong T, Smith G, et al.
CYT997 Causes apoptosis in human multiple myeloma. [JOURNAL ARTICLE]
Invest New Drugs 2009 Nov 12.
Abstract | Full Citation | Find Related Articles | | Viale M, Cordazzo C, de Totero D, et al.
Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis. [JOURNAL ARTICLE]
Invest New Drugs 2009 Oct 30.
Abstract | Full Citation | | Nagendraprabhu P, Sudhandiran G
Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. [JOURNAL ARTICLE]
Invest New Drugs 2009 Oct 30.
Abstract | Full Citation | | Singh RK, Lange TS, Kim KK, et al.
A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. [JOURNAL ARTICLE]
Invest New Drugs 2009 Oct 29.
Abstract | Full Citation | | Colon J, Basha MR, Madero-Visbal R, et al.
Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice. [JOURNAL ARTICLE]
Invest New Drugs 2009 Oct 23.
Abstract | Full Citation | | Manikandan P, Vinothini G, Vidya Priyadarsini R, et al.
Eugenol inhibits cell proliferation via NF-kappaB suppression in a rat model of gastric carcinogenesis induced by MNNG. [JOURNAL ARTICLE]
Invest New Drugs 2009 Oct 23.
Abstract | Full Citation | Find Related Articles | | Kudugunti SK, Vad NM, Ekogbo E, et al.
Efficacy of Caffeic Acid Phenethyl Ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice. [JOURNAL ARTICLE]
Invest New Drugs 2009 Oct 21.
Abstract | Full Citation | | Ramaswamy B, Mrozek E, Kuebler JP, et al.
Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer. [JOURNAL ARTICLE]
Invest New Drugs 2009 Oct 21.
Abstract | Full Citation | | Diaz LA, Messersmith W, Sokoll L, et al.
TNF-blockade in patients with advanced hormone refractory prostate cancer. [JOURNAL ARTICLE]
Invest New Drugs 2009 Oct 21.
Full Citation |   |
|
| |
Advertise on this site.
|
